Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) filed a Form 8-K with the Securities and Exchange Commission on February 13, 2026, disclosing a material event.
Sensei Biotherapeutics, Inc.'s stock currently trades at $9.09 with a market capitalization of $11.2M. The Healthcare company's stock moved following the disclosure.